HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

21,23-dithiaporphyrin

structure in first source

Also Known As:

5,10,15,20-tetrakis(4-sulfophenyl)-21,23-dithiaporphyrin, sodium salt

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Photosensitivity Disorders (Photodermatitis) 10/01/1999 - "The results of these experiments confirmed that 21-thiaporphyrin, 21,23-dithiaporphyrin and 21-oxaporphyrin can be considered as potent tumor photosensitizers that do not exert any unwanted effects, primarily skin photosensitization. "
2.	Neoplasms (Cancer) 10/01/1999 - "New potent sensitizers for photodynamic therapy: 21-oxaporphyrin, 21-thiaporphyrin and 21,23-dithiaporphyrin induce extensive tumor necrosis." 10/01/1999 - "The results of these experiments confirmed that 21-thiaporphyrin, 21,23-dithiaporphyrin and 21-oxaporphyrin can be considered as potent tumor photosensitizers that do not exert any unwanted effects, primarily skin photosensitization. "
3.	Necrosis 10/01/1999 - "New potent sensitizers for photodynamic therapy: 21-oxaporphyrin, 21-thiaporphyrin and 21,23-dithiaporphyrin induce extensive tumor necrosis."

Related Drugs and Biologics

1.	Photosensitizing Agents (Photosensitizers)
2.	21-oxaporphyrin
3.	5,20- bis(4- sulfophenyl)- 10,15- bis(2- methoxy- 4- sulfophenyl)- 21- thiaporphyrin

Related Therapies and Procedures

1.	Photochemotherapy (Photodynamic Therapy)